Cook Medical News

Cook Medical Expands Next-Generation NavAlign™ System for IVC Filter Placement with Femoral Access Option

David McCarty — Mon, 15 Mar 2010 00:00:00 EDT

Tampa, Fla., March 16, 2010 — Physicians placing inferior vena cava (IVC) filters to prevent life-t-hreatening pulmonary emboli now have access to the latest iteration of Cook Medical's advanced NavAlign&$8482; delivery system, a deployment system designed to minimize the risk of vessel trauma and streamline filter placement. The new NavAlign femoral delivery system, to be launched today in booth #406 at the SIR Annual Scientific Meeting, complements the already available jugular access version.

Cook Medical Offers Educational Sessions at Society of Interventional Radiology Annual Scientific Meeting

Marsha Lovejoy — Wed, 10 Mar 2010 00:00:00 EST

Tampa, Fla., March 12, 2010 — Cook Medical will host several in-booth sessions as part of its commitment to further physician education and enhance the dialogue around key topics at the Society of Interventional Radiology 35th Annual Scientific Meeting. Led by prominent physicians, the sessions will cover issues impacting interventional radiology today, including the treatment of pelvic congestion, lymphatic malformations and abdominal aortic aneurysms.

Comprehensive Online Resource for Soft Tissue Repair Adds New Dynamic Content, Features

Marsha Lovejoy — Mon, 8 Mar 2010 00:00:00 EST

Bloomington, Ind., March 8, 2010 — In response to its first-ever microsite on advanced soft tissue repair, Cook Medical has expanded CookBiodesign.com with new features including Q&A physician videos on biologics and links to the latest peer-reviewed articles, research and data on its Biodesign® Advanced Tissue Repair Products. The expanded site now offers surgeons and patients more than 800 educational resources on Biodesign products, which have been used in one million procedures and more than 91 countries for the treatment of conditions such as hernia, fistula, incontinence, pelvic organ prolapse and Peyronie's disease.

Cook Medical's Hercules 3 Stage Esophageal Balloon, Used to Treat Gastrointestinal Strictures, Now Available in U.S., Australia, Canada and Europe

David McCarty — Fri, 5 Mar 2010 00:00:00 EST

WINSTON-SALEM, N.C., March 5, 2010 ― Gastrointestinal (GI) strictures are abnormal narrowings of the digestive tract that, if left untreated, can dangerously interfere with eating, swallowing and digestion. Developed to treat such strictures, the Cook Medical Hercules® 3 Stage Esophageal Balloon is now available in the U.S., Australia, Canada and Europe after receiving 510(k) clearance and CE Mark certification, expanding Cook's offering of the most comprehensive line of devices for the endoscopy market.

Cook Pharmica Names Veda Walcott Vice President of Quality

Marsha Lovejoy — Mon, 1 Mar 2010 00:00:00 EST

BLOOMINGTON, Ind., March 1, 2010 — Veda Walcott has been named vice president of quality and corporate compliance officer of Cook Pharmica, the global biopharmaceutical contract development and manufacturing division of Cook Medical. She has been an employee of Cook Pharmica since 2005, and in her new role will be responsible for leading Cook Pharmica's quality and compliance programs and will oversee regulatory and validation support activities.

Clinical Study: Biologic Grafts Reduce Postoperative Pain While Creating a Repair as Durable as Synthetic Mesh in Treating Inguinal Hernias

Marsha Lovejoy — Wed, 10 Feb 2010 00:00:00 EST

Bloomington, Ind., February 10, 2010 — Results from a clinical study led by Luca Ansaloni, MD, showed that Cook Medical's Biodesign Inguinal Hernia Graft causes less postoperative pain and discomfort while creating a repair as durable as synthetic mesh when used in Lichtenstein's hernioplasty procedures. As published in a recent issue of the American Journal of Surgery, the three-year, 70-patient study determined that patients treated with Biodesign Inguinal Hernia Graft experienced a lower level of postoperative pain as compared with synthetic mesh-based procedures.

Cook Medical Showcases New Product Line for Improving PAD Patient Outcomes at LINC 2010

Anna Gueldenhaupt — Wed, 27 Jan 2010 00:00:00 EST

LEIPZIG, Germany, 27 January 2010 — This year's Leipzig Interventional Course sees Cook Medical roll out a range of innovative products aimed at improving treatment options for the 27 million people in Europe and North America affected with some form of peripheral arterial disease (PAD) and other diseases of the circulatory system.

Cook Medical Showcases Latest Advancements for Treating Vascular Disease at ISET 2010

David McCarty — Tue, 19 Jan 2010 00:00:00 EST

Miami, Fla., January 19, 2010 — Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy. In addition to live and simulated device demonstrations in booth #208, Cook's activities at the meeting include data presentations from two ongoing clinical trials and breakout sessions on common and debilitating conditions such as varicocele.

Healthy Growth for Aussie Medical Device Maker

David McCarty — Tue, 19 Jan 2010 00:00:00 EST

Brisbane, Australia, December 21, 2009 — Australian-born medical breakthroughs and an increasing emphasis on minimally invasive surgery are proving healthy growth engines for local medical device manufacturer William A. Cook Australia at it starts its fourth decade in business here.

Cook Names Nicky James Vice President and Global Leader of its Urology Strategic Business Unit

David McCarty — Wed, 13 Jan 2010 00:00:00 EST

Bloomington, Ind., January 13, 2010 — Nicky James, who has held a variety of positions within the Cook Medical, has been named vice president and global leader of the company's urology business unit. She succeeds Jerry French, a senior executive with more than 20 years of leadership within theat Cook organization, who is assuming other senior management duties within the company.

Physicians in Canada to Achieve Greater Levels of Control During Thoracic Endovascular Aneurysm Repair

David McCarty — Wed, 6 Jan 2010 00:00:00 EST

Bloomington, Ind., January 6, 2010 — Canadian physicians performing thoracic endovascular aneurysm repair (TEVAR7#41; can now achieve even greater levels of control, proximal conformity and apposition with Cook Medical's new Zenith® TX2® TAA Endovascular Graft with Pro-Form™. The technology, approved by Health Canada, is specifically designed for patients with tight aortic arches that are traditionally difficult to seal. TX2 with Pro-Form utilizes an improved delivery system that allows physicians to achieve unrivaled proximal conformity and apposition of the device to the aortic wall, virtually eliminating the 'bird's beak' gap.

First and Only International Study of its Kind Shakes up Metal Biliary Stent Market

David McCarty — Mon, 7 Dec 2009 00:00:00 EST

WINSTON-SALEM, N.C., December 2, 2009 — The final results of the largest international, randomized, controlled trial of self-expanding metal stents (SEMS) in the treatment of biliary obstructions reveal a new, disruptive competitive dynamic in the $70-100 million metal stent market. The study, known as MOZART, published in the September issue of Gastrointestinal Endoscopy, found that the overall clinical success of Cook Medical's non-foreshortening nitinol Zilver® Biliary Stent, now available on a 25 percent smaller 6 FR introducer, parallels the effectiveness of Boston Scientific's Wallstent®. The MOZART study confirms that SEMS provide a higher level of patient care and clinical efficacy than alternative solutions.

Cook Medical's Women's Health Division Expands in China

Gail McDaniel — Wed, 25 Nov 2009 00:00:00 EST

Hong Kong, November 25, 2009 — Cook Medical today announces that its Women's Health Global Business Unit is expanding its emphasis on providing world-class medical care for female patients in China, particularly in the areas of high-risk obstetrics, gynecology and assisted reproductive technology (A.R.T.).

New Laparoscopy Tools Advance Care for Common Gynecological Ailments

Gail McDaniel — Mon, 23 Nov 2009 00:00:00 EST

Orlando, Fla., November 23, 2009 — Laparoscopic surgeons received their first glimpse of Cook Medical's uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).

Cook Medical Drives Industry Innovation at 23rd Congress of the Japanese Society of Endourology and ESWL

Gail McDaniel — Mon, 9 Nov 2009 00:00:00 EST

Bloomington, Ind., November 9, 2009 — In an ongoing effort to drive innovation in endourology, Cook Medical will feature a series of product demonstrations with a special emphasis on the PERC NCircle® Nitinol Tipless Stone Extractor, Flexor® Ureteral Access Sheath and the Ultraxx™ Nephrostomy Balloon at the 23rd Congress of the Japanese Society of Endourology and ESWL (extracorporeal shock wave lithotripsy), in Tokyo, Japan.

Early Detection Screening Offered at AOPA Aviation Summit for Abdominal Aortic Aneurysms

David McCarty — Wed, 4 Nov 2009 00:00:00 EST

Bloomington, Ind. – November 4, 2009 — Cook Medical is partnering with the Aircraft Owners and Pilots Association (AOPA) at this year's AOPA Aviation Summit in Tampa, Fla. from November 5-7 to provide free abdominal aortic aneurysm (AAA) screenings to its attendees at high risk for AAA. Preventive screenings for AAAs, a “silent killer” and the 10th leading cause of death in the U.S. in men over age 55, have proven effective in detecting the condition early and enabling interventional treatment.

First Device Designed to Preserve Blood Flow to Iliac Arteries During Aneurysm Repair Receives Approval from Health Canada

David McCarty — Wed, 4 Nov 2009 00:00:00 EST

Bloomington, Ind. – November 4, 2009 — Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the body's largest arteries with an endovascular graft delivered during a minimally invasive procedure without blocking a critical artery. The Zenith® Branch Endovascular Graft-Iliac Bifurcation from Cook Medical, approved today by Health Canada's Medical Devices Bureau, is specifically designed to preserve flow to the internal iliac artery allowing for the endovascular treatment of both aortoiliac and iliac artery aneurysms that commonly occur in patients with abdominal aortic aneurysms (AAA). Aneurysms are bulges in the walls of the major arteries that left untreated can rupture causing death.

Cook Japan Appoints General Manager

Yuriko Yamamoto — Mon, 26 Oct 2009 00:00:00 EDT

Tokyo, Japan, October 26, 2009 — Glenn Ostlund, Representative Director of Cook Japan announced the appointment of Kazuhiko Yagome as General Manager as part of a diverse investment to promote new growth and development at Cook Japan. Cook Japan was established in 2004, expanding Cook's investment into Japan and the Asia Pacific market. With his extensive management experience, Mr. Yagome will reinforce Cook Japan's business structure through partnership of cross-functional departments and active communication.

Cook Medical Unveils FluoroSet™ To Aid Diagnosis of Tubal Occlusion

Gail McDaniel — Mon, 26 Oct 2009 00:00:00 EDT

Bloomington, Ind., October 26, 2009 — Approximately one million women in the United States are rendered infertile by disease in the fallopian tubes, the most common being tubal occlusion or blockage. This condition is commonly diagnosed using a complicated, invasive fluoroscopic evaluation, consisting of real-time, action images of the fallopian tubes to identify possible occlusions. In an effort to simplify this procedure and ease patient discomfort, Cook Medical today announced the availability of the FluoroSet, a comprehensive, three-product radiographic tubal assessment set designed to deliver fast, easy, accurate fluoroscopic evaluation results.

Cook Medical Unveils an Integrated Line of New Devices to Improve Peripheral Arterial Disease Patient Outcomes

David McCarty — Tue, 20 Oct 2009 00:00:00 EDT

LAS VEGAS, Nev. - October 20, 2009 - In a tour de force of new product development and introduction, Cook Medical is introducing six new products in parallel to provide better treatment options to the physicians treating the 27 million people worldwide* afflicted with some form of peripheral arterial disease (PAD) and other diseases of the circulatory system.